@mevoireview23_1: Kem bôi da Thuần Mộc Kids không chưa Corticoid nên bé từ sơ sinh dùng được rồi các mẹ ạ #kemboidachobe #thuanmockids #kemboithuanmoc #rôm_sảy #mevoireview

Mẹ Voi review ✅
Mẹ Voi review ✅
Open In TikTok:
Region: VN
Thursday 02 July 2026 12:05:00 GMT
614
33
31
3

Music

Download

Comments

nhapinhoxiu
Nhà Pi Nhỏ Xíu 🍇 :
Kem này bôi trộm vía nhanh dịu da lắm nha, đi đâu mang theo cũng tiện
2026-07-02 16:54:27
0
medoro02
Mẹ Đô Rô :
Mình đang dùng cho con hiệu quả lắm
2026-07-02 15:15:13
0
banhbaodayroine
Bánh Bao Đây Rồi! 👼🏻 :
Loại này mình thấy dùng hiệu quả nè
2026-07-03 02:23:12
0
lananh.meemmia
✨Lan Anh - Mẹ em Mía✨ :
Oke nè
2026-07-02 18:41:17
0
chipxiu2024
Mẹ Xíu Chíp ❤ :
Kem này nhạy bé mình cũng xài
2026-07-02 16:10:41
0
em.b.la.cung.thin
Mẹ Linh của Đổ La🩵 :
Oki lắm nek
2026-07-03 05:48:51
0
mekemvuitinh
Mẹ Kem vui tính :
Kem nhạy lắm nè
2026-07-02 23:27:32
0
mesocsan
Mẹ Sóc San :
Thuần mộc mình thấy OK thật
2026-07-02 15:24:48
0
nhathibap1504
𝓑ắ𝓹 𝓲𝓾 đâ𝔂𝔂𝔂 👧🏻🌽 :
Để tui tk nè
2026-07-03 05:19:58
0
bongxoixinchao
Bông Xôi xin chào 🍀 :
hay nha
2026-07-02 15:48:18
0
huyen0596
Mẹ BiBo :
Ui để mình thử cho Bi. Chuyên gia bị ngứa vào mùa này
2026-07-04 16:11:14
0
thanh_xinh.92
Mẹ Sóc :
Chân ái lun
2026-07-02 15:06:59
0
sociuoii24
Mẹ em Sóc 🐿️ :
Nhạy lắm
2026-07-02 15:02:36
0
trangthumetom
Trang Thư (Mẹ Tôm) :
Kem bôi nhạy lắm mom
2026-07-02 15:11:55
0
me2embemuoivung
Mẹ Muối Vừng :
Dùng hiệu quả lắm nha bà
2026-07-02 13:58:32
0
gau.mot.mi
Gấu Một Mí 🐻 :
Chân ái mom oi
2026-07-02 13:53:35
0
havie_zy04
Mẹ của Tròn 👼 :
chân ái
2026-07-02 13:47:24
0
mexoaithai
Mẹ Xoài Thái :
Dùng oke lắm
2026-07-02 13:46:34
0
mecon.topmo
mecon.topmo🥝 :
Bé t dùng mấy ngày là da dịu lại, tv lắm
2026-07-02 14:42:11
0
mecua3ebee
Mẹ Của 3 Em Bé :
Kem này nhạy lm
2026-07-02 13:34:03
0
trangtoan2024
Mẹ và Em Puu :
Nhà tui dùng hiệu quả lắm
2026-07-02 13:26:15
0
kenhchiboemsua
KÊNH CHỊ BƠ 🥑 EM SỮA 🍼 :
dùng hiệu quả lắm
2026-07-02 13:18:35
0
nhinhi1602
𝐌𝐞̣ 𝐛𝐞́ 𝐗𝐨𝐚̀𝐢 🥭 :
Dùng ok
2026-07-02 13:07:38
0
thienly31102
Mẹ CuNo :
Em kem này dịu ạ
2026-07-02 13:05:26
0
yanalink15
Mẹ Linh Có Em Dâu :
Em này nhạy nha
2026-07-02 12:12:03
0
To see more videos from user @mevoireview23_1, please go to the Tikwm homepage.

Other Videos

on august 19 2026 moderna and merck announced the first successful late-stage results for a personalized mrna cancer vaccine. the vaccine is called intismeran (also known as intismeran autogene or previously mrna-4157/v940). it was tested in combination with merck’s immunotherapy drug keytruda in a phase 3 trial involving 1137 patients with high-risk stage iib to iv melanoma whose tumors had already been surgically removed. the trial met both its main goal of improving recurrence-free survival and a key secondary goal of improving distant metastasis-free survival. in plain terms the vaccine plus keytruda made it less likely for the melanoma to come back or spread to other parts of the body compared with keytruda alone. this is the first time a personalized neoantigen mrna cancer vaccine has succeeded in a large randomized phase 3 study. how it works: doctors sequence the patient’s tumor, identify unique mutations called neoantigens (up to 34 of them), and then use mrna technology to create a custom vaccine that teaches the immune system to recognize and attack those specific cancer markers. the whole manufacturing process takes roughly six weeks. earlier smaller trials had already shown roughly a 49 percent reduction in the risk of recurrence or death and a 59 percent reduction in the risk of distant spread or death over five years. the companies have not released the full detailed numbers yet but plan to present them at an upcoming medical conference. they are already talking with regulators about possible approval. some reports suggest the treatment could reach patients as early as next year if everything moves quickly. several sources also note that ai tools helped with selecting the best neoantigen targets for each patient. #larpochka #techtok #llm #machinelearning #claude
on august 19 2026 moderna and merck announced the first successful late-stage results for a personalized mrna cancer vaccine. the vaccine is called intismeran (also known as intismeran autogene or previously mrna-4157/v940). it was tested in combination with merck’s immunotherapy drug keytruda in a phase 3 trial involving 1137 patients with high-risk stage iib to iv melanoma whose tumors had already been surgically removed. the trial met both its main goal of improving recurrence-free survival and a key secondary goal of improving distant metastasis-free survival. in plain terms the vaccine plus keytruda made it less likely for the melanoma to come back or spread to other parts of the body compared with keytruda alone. this is the first time a personalized neoantigen mrna cancer vaccine has succeeded in a large randomized phase 3 study. how it works: doctors sequence the patient’s tumor, identify unique mutations called neoantigens (up to 34 of them), and then use mrna technology to create a custom vaccine that teaches the immune system to recognize and attack those specific cancer markers. the whole manufacturing process takes roughly six weeks. earlier smaller trials had already shown roughly a 49 percent reduction in the risk of recurrence or death and a 59 percent reduction in the risk of distant spread or death over five years. the companies have not released the full detailed numbers yet but plan to present them at an upcoming medical conference. they are already talking with regulators about possible approval. some reports suggest the treatment could reach patients as early as next year if everything moves quickly. several sources also note that ai tools helped with selecting the best neoantigen targets for each patient. #larpochka #techtok #llm #machinelearning #claude

About